US Patent:
20110182918, Jul 28, 2011
Inventors:
Matthew Kalnik - Bedminster NJ, US
Matthew Hohenboken - Potomac MD, US
Paul Kessler - Hagerstown MD, US
Ali Fattom - Rockville MD, US
Raafat Fahim - Boca Raton FL, US
Leslie Hudson - Bend OR, US
International Classification:
A61K 39/00
A61K 39/395
A61P 25/30
A61P 25/34
A61P 25/36
G01N 33/53
US Classification:
4241751, 4241841, 435 792
Abstract:
Described are smoking cessation devices and kits for determining an advantageous time for a subject to quit smoking, and/or for extending the duration of smoking abstinence, based on serum levels of anti-nicotine antibodies, and personalized drug treatment methods, including methods and kits for the treatment and prevention of drug addiction, drug use and drug abuse, which include determining the subject's pre-vaccine levels of antibodies specific for the drug hapten at issue. Related methods are also described.